M&A Deal Summary

SOL Global Investments Acquires GreenLight Medicines

On January 2, 2019, SOL Global Investments acquired consumer products company GreenLight Medicines

Acquisition Highlights
  • This is SOL Global Investments’ 1st transaction in the Consumer Products sector.
  • This is SOL Global Investments’ 1st transaction in Ireland.

M&A Deal Summary

Date 2019-01-02
Target GreenLight Medicines
Sector Consumer Products
Buyer(s) SOL Global Investments
Deal Type Add-on Acquisition

Target

GreenLight Medicines

Dublin, Ireland
GreenLight Pharmaceuticals Ltd. is a vertically-integrated medical cannabis company with a clinical research and development operation.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

SOL Global Investments

Toronto, Ontario, Canada

Category Company
Sector Business Services
DESCRIPTION

SOL Global Investments Corp. is an international investment company with a focus on cannabis and cannabis-related companies in legal U.S. states. SOL Global Investments is based in Toronto, Ontario.


DEAL STATS #
Overall 1 of 7
Sector: Consumer Products M&A 1 of 4
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Ireland M&A 1 of 1
Year: 2019 M&A 1 of 6
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-26 Jones Soda

Seattle, Washington, United States

Jones Soda markets and distributes beverages under the Jones Soda and Lemoncocco brands. The diverse product line of Jones offers something for everyone - pure cane sugar soda, zero-calorie soda, and Lemoncocco non-carbonated refreshment. Jones Soda was founded in 1986 and is based in Seattle, Washington.

Buy -